Genetic epidemiology of type 1 diabetes

Pediatric Diabetes

Volumn 4, Issue 2, 2003, Pages 87-100

  Hirschhorn, Joel N ^a,b,c  

^a BOSTON CHILDREN S HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

Author keywords

Epidemiology; Genetics; HLA; Insulin; Type 1 diabetes

Indexed keywords

ENVIRONMENTAL FACTOR; FEMALE; GENDER; GENE LOCUS; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC EPIDEMIOLOGY; GENETIC PREDISPOSITION; GENETIC SUSCEPTIBILITY; HUMAN; IMMUNOPATHOLOGY; INSULIN DEPENDENT DIABETES MELLITUS; LINKAGE ANALYSIS; MALE; PRIORITY JOURNAL; REVIEW;

CHROMOSOME MAPPING; DIABETES MELLITUS, TYPE 1; FEMALE; HUMANS; MALE; PEDIGREE;

EID: 0038049458     PISSN: 1399543X     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1399-5448.2001.00013.x     Document Type: Review

References (163)

1. Bell GI, Polonsky KS. Diabetes mellitus and genetically programmed defects in beta-cell function. Nature 2001: 414: 788-791.
2. Van Den Ouweland JM, Lemkes HH, Ruitenbeek W et al. Mutation in mitochondrial tRNA (Leu) (UUR) gene in a large pedigree with maternally transmitted type II diabetes mellitus and deafness. Nat Genet 1992: 1: 368-371.
3. Barrett TG, Bundey SE. Wolfram (DIDMOAD) syndrome. J Med Genet 1997: 34: 838-841.
4. Ahonen P. Autoimmune polyendocrinopathy - candidosis - ectodermal dystrophy (APECED): autosomal recessive inheritance. Clin Genet 1985: 27: 535-542.
5. Bhayana S, Hegele RA. The molecular basis of genetic lipodystrophies. Clin Biochem. 2002: 35: 171-177.
6. Roy CN, Andrews NC. Recent advances of disorders of iron metabolism: mutations, mechanisms and modifiers. Hum Mol Genet 2001: 10: 2181-2186.
7. Groop LC, Bottazzo GF, Doniach D. Islet cell antibodies identify latent type I diabetes in patients aged 35-75 years at diagnosis. Diabetes 1986: 35: 237-241.
8. Tuomi T, Carlsson A, Li H et al. Clinical and genetic characteristics of type 2 diabetes with and without GAD antibodies. Diabetes 1999: 48: 150-157.
9. Sobngwi E, Mauvais-Jarvis F, Vexiau P, Mbanya JC, Gautier JF. Diabetes in Africans. Part 2: Ketosisprone atypical diabetes mellitus. Diabetes Metab 2002: 28: 5-12.
10. Karvonen M, Viik-Kajander M, Moltchanova E et al. Incidence of childhood type 1 diabetes worldwide. Diabetes Mondiale (Diamond) Project Group. Diabetes Care 2000: 23: 1516-1526.
11. Onkamo P, Vaananen S, Karvonen M, Tuomilehto J. Worldwide increase in incidence of type I diabetes - the analysis of the data on published incidence trends. Diabetologia 1999: 42: 1395-1403.
12. Green A, Patterson CC. Trends in the incidence of childhood-onset diabetes in Europe 1989-98. Diabetologia 2001: 44(Suppl. 3): B3-8.
13. Tuomilehto J, Karvonen M, Pitkaniemi J et al. Record-high incidence of Type I (insulin-dependent) diabetes mellitus in Finnish children. The Finnish Childhood Type I Diabetes Registry Group. Diabetologia 1999: 42: 655-660.
14. Karvonen M, Pitkaniemi J, Tuomilehto J. The onset age of type 1 diabetes in Finnish children has become younger. The Finnish Childhood Diabetes Registry Group. Diabetes Care 1999: 22: 1066-1070.
15. Muntoni S, Fonte MT, Stoduto S et al. Incidence of insulin-dependent diabetes mellitus among Sardinian-heritage children born in Lazio region, Italy. Lancet 1997: 349: 160-162.
16. Siemiatycki J, Colle E, Campbell S et al. Incidence of IDDM in Montreal by ethnic group and by social class and comparisons with ethnic groups living elsewhere. Diabetes 1988: 37: 1096-1102.
17. Spielman RS, Baker L, Zmijewski CM. Gene dosage and suceptibility to insulin-dependent diabetes. Ann Hum Genet 1980: 44: 135-150.
18. Risch N. Linkage strategies for genetically complex traits. I. Multilocus models. Am J Hum Genet 1990: 46: 222-228.
19. Boomsma D, Busjahn A, Peltonen L. Classical twin studies and beyond. Nat Rev Genet 2002: 3: 872-882.
20. Redondo MJ, Fain PR, Eisenbarth GS. Genetics of type 1A diabetes. Recent Prog Horm Res 2001: 56: 69-89.
21. Kyvik KO, Green A, Beck-Nielsen H. Concordance rates of insulin dependent diabetes mellitus. a population based study of young Danish twins. BMJ 1995: 311: 913-917.
22. Redondo MJ, Yu L, Hawa M et al. Heterogeneity of type I diabetes: analysis of monozygotic twins in Great Britain and the United States. Diabetologia 2001: 44: 354-362.
23. Kumar D, Gemayel NS, Deapen D et al. North-American twins with IDDM. Genetic, etiological, and clinical significance of disease concordance according to age, zygosity, and the interval after diagnosis in first twin. Diabetes 1993: 42: 1351-1363.
24. Fava D, Gardner S, Pyke D, Leslie RD. Evidence that the age at diagnosis of IDDM is genetically determined. Diabetes Care 1998: 21: 925-929.
25. a Kaprio J, Tuomilehto J, Koskenvuo M et al. Concordance for type 1 (insulin-dependent) and type 2 (non-insulin-dependent) diabetes mellitus in a population-based cohort of twins in Finland. Diabetologia 1992: 35: 1060-1067.
26. Olmos P, A'Hern R, Heaton DA et al. The significance of the concordance rate for type 1 (insulin-dependent) diabetes in identical twins. Diabetologia 1988: 31: 747-750.
27. Riley WJ, Maclaren NK, Krischer J et al. A prospective study of the development of diabetes in relatives of patients with insulin-dependent diabetes. N Engl J Med 1990: 323: 1167-1172.
28. Verge CF, Gianani R, Kawasaki E et al. Prediction of type I diabetes in first-degree relatives using a combination of insulin, GAD, and ICA512bdc/IA-2 autoantibodies. Diabetes 1996: 45: 926-933.
29. Bonifacio E, Bingley PJ, Shattock M et al. Quantification of islet-cell antibodies and prediction of insulin-dependent diabetes. Lancet 1990: 335: 147-149.
30. Petersen JS, Kyvik KO, Bingley PJ et al. Population based study of prevalence of islet cell autoantibodies in monozygotic and dizygotic Danish twin pairs with insulin dependent diabetes mellitus. Bmj 1997: 314: 1575-1579.
31. Redondo MJ, Rewers M, Yu L et al. Genetic determination of islet cell autoimmunity in monozygotic twin, dizygotic twin, and non-twin siblings of patients with type 1 diabetes: prospective twin study. Bmj 1999: 318: 698-702.
32. Levy-Marchal C, Patterson C, Green A. Variation by age group and seasonality at diagnosis of childhood IDDM in Europe. The EURODIAB ACE Study Group. Diabetologia 1995: 38: 823-830.
33. Rothwell PM, Staines A, Smail P, Wadsworth E, McKinney P. Seasonality of birth of patients with childhood diabetes in Britain. Br Med J 1996: 312: 1456-1457.
34. Jongbloet PH, Groenewoud HM, Hirasing RA, Van Buuren S. Seasonality of birth in patients with childhood diabetes in The Netherlands. Diabetes Care 1998: 21: 190-191.
35. Kida K, Mimura G, Ito T et al. Incidence of type 1 diabetes mellitus in children aged 0-14 in Japan, 1986-90, including an analysis for seasonality of onset and month of birth. JDS study. The Data Committee for Childhood Diabetes of the Japan Diabetes Society (JDS). Diabet Med 2000: 17: 59-63.
36. Menser MA, Forrest JM, Bransby RD. Rubella infection and diabetes mellitus. Lancet 1978: 1: 57-60.
37. McIntosh ED, Menser MA. A fifty-year follow-up of congenital rubella. Lancet 1992: 340: 414-415.
38. Von Herrath MG, Holz A, Homann D, Oldstone MB. Role of viruses in type I diabetes. Semin Immunol 1998: 10: 87-100.
39. Robles DT, Eisenbarth GS. Type 1A diabetes induced by infection and immunization. J Autoimmun 2001: 16: 355-362.
40. Hyoty H, Taylor KW. The role of viruses in human diabetes. Diabetologia 2002: 45: 1353-1361.
41. Kaufman DL, Erlander MG, Clare-Salzler M et al. Autoimmunity to two forms of glutamate decarboxylase in insulin-dependent diabetes mellitus. J Clin Invest 1992: 89: 283-292.
42. Effects of insulin in relatives of patients with type 1 diabetes mellitus. N Engl J Med 2002: 346: 1685-1691.
43. Honeyman MC, Coulson BS, Stone NL et al. Association between rotavirus infection and pancreatic islet autoimmunity in children at risk of developing type 1 diabetes. Diabetes 2000: 49: 1319-1324.
44. Lonnrot M, Korpela K, Knip M et al. Enterovirus infection as a risk factor for beta-cell autoimmunity in a prospectively observed birth cohort: the Finnish Diabetes Prediction and Prevention Study. Diabetes 2000: 49: 1314-1318.
45. Dahlquist GG, Ivarsson S, Lindberg B, Forsgren M. Maternal enteroviral infection during pregnancy as a risk factor for childhood IDDM. A population-based case-control study. Diabetes 1995: 44: 408-413.
46. Hyoty H, Hiltunen M, Knip M et al. A prospective study of the role of coxsackie B and other enterovirus infections in the pathogenesis of IDDM. Childhood Diabetes Finland (Dime) Study Group. Diabetes 1995: 44: 652-657.
47. Virtanen SM, Rasanen L, Ylonen K et al. Early introduction of dairy products associated with increased risk of IDDM in Finnish children. The Childhood Diabetes Finland Study Group Diabetes 1993: 42: 1786-1790.
48. Levy-Marchal C, Karjalainen J, Dubois F et al. Antibodies against bovine albumin and other diabetes markers in French children. Diabetes Care 1995: 18: 1089-1094.
49. Cavallo MG, Fava D, Monetini L, Barone F, Pozzilli P. Cell-mediated immune response to beta casein in recent-onset insulin- dependent diabetes: implications for disease pathogenesis. Lancet 1996: 348: 926-928.
50. Hypponen E, Kenward MG, Virtanen SM et al. Infant feeding, early weight gain, and risk of type 1 diabetes. Childhood Diabetes Finland (Dime) Study Group. Diabetes Care 1999: 22: 1961-1965.
51. Hypponen E, Virtanen SM, Kenward MG, Knip M, Akerblom HK. Obesity, increased linear growth, and risk of type 1 diabetes in children. Diabetes Care 2000: 23: 1755-1760.
52. Hypponen E, Laara E, Reunanen A, Jarvelin MR, Virtanen SM. Intake of vitamin D and risk of type 1 diabetes: a birth-cohort study. Lancet 2001: 358: 1500-1503.
53. Warram JH, Krolewski AS, Gottlieb MS, Kahn CR. Differences in risk of insulin-dependent diabetes in offspring of diabetic mothers and diabetic fathers. N Engl J Med 1984: 311: 149-152.
54. Bleich D, Polak M, Eisenbarth GS, Jackson RA. Decreased risk of type I diabetes in offspring of mothers who acquire diabetes during adrenarchy. Diabetes 1993: 42: 1433-1439.
55. Karvonen M, Pitkaniemi M, Pitkaniemi J et al. Sex difference in the incidence of insulin-dependent diabetes mellitus: an analysis of the recent epidemiological data. World Health Organization DIAMOND Project Group. Diabetes Metab Rev 1997: 13: 275-291.
56. Cucca F, Goy JV, Kawaguchi Y et al. A male-female bias in type 1 diabetes and linkage to chromosome Xp in MHC HLA-DR3-positive patients. Nat Genet 1998: 19: 301-302.
57. Thomson G, Robinson WP, Kuhner MK et al. Genetic heterogeneity, modes of inheritance, and risk estimates for a joint study of Caucasians with insulin-dependent diabetes mellitus. Am J Hum Genet 1988: 43: 799-816.
58. Field LL. Genetic linkage and association studies of type I diabetes: challenges and rewards. Diabetologia 2002: 45: 21-35.
59. Lander E, Kruglyak L. Genetic dissection of complex traits: guidelines for interpreting and reporting linkage results. Nat Genet 1995: 11: 241-247.
60. Rao DC, Province MA. The future of path analysis, segregation analysis, and combined models for genetic dissection of complex traits. Hum Hered 2000: 50: 34-42.
61. Risch N, Merikangas K. The future of genetic studies of complex human diseases. Science 1996: 273: 1516-1517.
62. Davies JL, Kawaguchi Y, Bennett ST et al. A genome-wide search for human type 1 diabetes susceptibility genes. Nature 1994: 371: 130-136.
63. Hashimoto L, Habita C, Beressi JP et al. Genetic mapping of a susceptibility locus for insulin-dependent diabetes mellitus on chromosome 11q. Nature 1994: 371: 161-164.
64. Concannon P, Gogolin-Ewens KJ, Hinds DA et al. A second-generation screen of the human genome for susceptibility to insulin-dependent diabetes mellitus. Nat Genet 1998: 19: 292-296.
65. Mein CA, Esposito L, Dunn MG et al. A search for type 1 diabetes susceptibility genes in families from the United Kingdom. Nat Genet 1998: 19: 297-300.
66. Field LL, Tobias R, Magnus T. A locus on chromosome 15q26 (IDDM3) produces susceptibility to insulin- dependent diabetes mellitus. Nat Genet 1994: 8: 189-194.
67. Copeman JB, Cucca F, Hearne CM et al. Linkage disequilibrium mapping of a type 1 diabetes susceptibility gene (IDDM7) to chromosome 2q31-q33. Nat Genet 1995: 9: 80-85.
68. Luo DF, Bui MM, Muir A et al. Affected-sib-pair mapping of a novel susceptibility gene to insulin-dependent diabetes mellitus (IDDM8) on chromosome 6q25-q27. Am J Hum Genet 1995: 57: 911-919.
69. Rowe RE, Wapelhorst B, Bell GI et al. Linkage and association between insulin-dependent diabetes mellitus (IDDM) susceptibility and markers near the glucokinase gene on chromosome 7. Nat Genet 1995: 10: 240-242.
70. Field LL, Tobias R, Thomson G, Plon S. Susceptibility to insulin-dependent diabetes mellitus maps to a locus (IDDM11) on human chromosome 14q24.3-q31. Genomics 1996: 33: 1-8.
71. Morahan G, Huang D, Tait BD, Colman PG, Harrison LC. Markers on distal chromosome 2q linked to insulin-dependent diabetes mellitus. Science 1996: 272: 1811-1813.
72. Nistico L, Buzzetti R, Pritchard LE et al. The CTLA-4 gene region of chromosome 2q33 is linked to, and associated with, type 1 diabetes. Belgian Diabetes Registry. Hum Mol Genet 1996: 5: 1075-1080.
73. Reed P, Cucca F, Jenkins S et al. Evidence for a type 1 diabetes susceptibility locus (IDDM10) on human chromosome 10p11-q11. Hum Mol Genet 1997: 6: 1011-1016.
74. Delepine M, Pociot F, Habita C et al. Evidence of a non-MHC susceptibility locus in type I diabetes linked to HLA on chromosome 6. Am J Hum Genet 1997: 60: 174-187.
75. Merriman TR, Eaves IA, Twells RC et al. Transmission of haplotypes of microsatellite markers rather than single marker alleles in the mapping of a putative type 1 diabetes susceptibility gene (IDDM6). Hum Mol Genet 1998: 7: 517-524.
76. Verge CF, Vardi P, Babu S et al. Evidence for oligogenic inheritance of type 1 diabetes in a large Bedouin Arab family. J Clin Invest 1998: 102: 1569-1575.
77. Luo DF, Buzzetti R, Rotter JI et al. Confirmation of three susceptibility genes to insulin-dependent diabetes mellitus: IDDM4, IDDM5 and IDDM8. Hum Mol Genet 1996: 5: 693-698.
78. Lernmark A, Ott J. Sometimes it's hot, sometimes it's not. Nat Genet 1998: 19: 213-214.
79. Cox NJ, Wapelhorst B, Morrison VA et al. Seven regions of the genome show evidence of linkage to type 1 diabetes in a consensus analysis of 767 multiplex families. Am J Hum Genet 2001: 69: 820-830.
80. Cardon LR, Bell JI. Association study designs for complex diseases. Nat Rev Genet 2001: 2: 91-99.
81. Spielman RS, McGinnis RE, Ewens WJ. Transmission test for linkage disequilibrium. the insulin gene region and insulin-dependent diabetes mellitus (IDDM). Am J Hum Genet 1993: 52: 506-516.
82. Spielman RS, Ewens WJ. A sibship test for linkage in the presence of association: the sib transmission/disequilibrium test. Am J Hum Genet 1998: 62: 450-458.
83. Martin ER, Monks SA, Warren LL, Kaplan NL. A test for linkage and association in general pedigrees: the pedigree disequilibrium test. Am J Hum Genet 2000: 67: 146-154.
84. Lander ES, Schork NJ. Genetic dissection of complex traits. Science 1994: 265: 2037-2048.
85. Collins FS, Guyer MS, Charkravarti A. Variations on a theme: cataloging human DNA sequence variation. Science 1997: 278: 1580-1581.
86. Lohmueller KE, Pearce CL, Pike M, Lander ES, Hirschhorn JN. Meta-analysis of genetic association studies supports a contribution of common variants to susceptibility to common disease. Nat Genet, in press.
87. Hirschhorn JN, Lohmueller K, Byrne E, Hirschhorn K. A comprehensive review of genetic association studies. Genet Med 2002: 4: 45-61.
88. Kruglyak L, Nickerson DA. Variation is the spice of life. Nat Genet 2001: 27: 234-236.
89. Morton NE, Collins A. Tests and estimates of allelic association in complex inheritance. Proc Natl Acad Sci USA 1998: 95: 11389-11393.
90. Ardlie KG, Lunetta KL, Seielstad M. Testing for population subdivision and association in four case-control studies. Am J Hum Genet 2002: 71: 304-311.
91. Pritchard JK, Rosenberg NA. Use of unlinked genetic markers to detect population stratification in association studies. Am J Hum Genet 1999: 65: 220-228.
92. Devlin B, Roeder K. Genomic control for association studies. Biometrics 1999: 55: 997-1004.
93. Reich DE, Goldstein DB. Detecting association in a case-control siudy while correcting for population stratification. Genet Epidemiol 2001: 20: 4-16.
94. Pritchard JK, Stephens M, Rosenberg NA, Donnelly P. Association mapping in structured populations. Am J Hum Genet 2000: 67: 170-181.
95. Singal DP, Blajchman MA. Histocompatibility (HL-A) antigens, lymphocytotoxic antibodies and tissue antibodies in patients with diabetes mellitus. Diabetes 1973: 22: 429-432.
96. Cudworth AG, Woodrow JC. Letter: HL-A antigen and diabetes mellitus. Lancet 1974: 2: 1153.
97. Nerup J, Platz P, Andersen OO et al. HL-A antigens and diabetes mellitus. Lancet 1974: 2: 864-866.
98. Christy M, Green A, Christau B et al. Studies of the HLA system and insulin-dependent diabetes mellitus. Diabetes Care 1979: 2: 209-214.
99. Platz P, Jakobsen BK, Morling N et al. HLA-D and - DR antigens in genetic analysis of insulin dependent diabetes mellitus. Diabetologia 1981: 21: 108-115.
100. Schober E, Schernthaner G, Mayr WR. HLA-DR antigens in insulin-dependent diabetes. Arch Dis Child 1981: 56: 227-229.
101. Todd JA, Bell JI, McDevitt HO. HLA-DQ beta gene contributes to susceptibility and resistance to insulin-dependent diabetes mellitus. Nature 1987: 329: 599-604.
102. Zamani M, Cassiman JJ. Reevaluation of the importance of polymorphic HLA class II alleles and amino acids in the susceptibility of individuals of different populations to type I diabetes. Am J Med Genet 1998: 76: 183-194.
103. Todd JA, Mijovic C, Fletcher J et al. Identification of susceptibility loci for insulin-dependent diabetes mellitus by trans-racial gene mapping. Nature 1989: 338: 587-589.
104. Rotter JI, Anderson CE, Rubin R et al. HLA genotypic study of insulin-dependent diabetes the excess of DR3/DR4 heterozygotes allows rejection of the recessive hypothesis. Diabetes 1983: 32: 169-174.
105. Graham RR, Ortmann WA, Langefeld CD et al. Visualizing human leukocyte antigen class II risk haplotypes in human systemic lupus erythematosus. Am J Hum Genet 2002: 71: 543-553.
106. Lie BA, Todd JA, Pociot F et al. The predisposition to type 1 diabetes linked to the human leukocyte antigen complex includes at least one non-class II gene. Am J Hum Genet 1999: 64: 793-800.
107. Clerget-Darpoux F. The HLA component of type I diabetes. Am J Hum Genet 2000: 66: 1468.
108. Koeleman BP, Herr MH, Zavattari P et al. Conditional ETDT analysis of the human leukocyte antigen region in type 1 diabetes. Ann Hum Genet 2000: 64: 215-221.
109. Zavattari P, Lampis R, Motzo C et al. Conditional linkage disequilibrium analysis of a complex disease superlocus, IDDM1 in the HLA region, reveals the presence of independent modifying gene effects influencing the type 1 diabetes risk encoded by the major HLA-DQB1-DRB1 disease loci. Hum Mol Genet 2001: 10: 881-889.
110. Lucassen AM, Julier C, Beressi JP et al. Susceptibility to insulin dependent diabetes mellitus maps to a 4.1 kb segment of DNA spanning the insulin gene and associated VNTR. Nat Genet 1993: 4: 305-310.
111. Owerbach D, Gabbay KH. Localization of a type I diabetes susceptibility locus to the variable tandem repeat region flanking the insulin gene. Diabetes 1993: 42: 1708-1714.
112. Bell GI, Horita S, Karam JH. A polymorphic locus near the human insulin gene is associated with insulin-dependent diabetes mellitus. Diabetes 1984: 33: 176-183.
113. Bennett ST, Lucassen AM, Gough SC et al. Susceptibility to human type 1 diabetes at IDDM2 is determined by tandem repeat variation at the insulin gene minisatellite locus. Nat Genet 1995: 9: 284-292.
114. Bennett ST, Todd JA. Human type 1 diabetes and the insulin gene: principles of mapping polygenes. Annu Rev Genet 1996: 30: 343-370.
115. Vafiadis P, Bennett ST, Todd JA et al. Insulin expression in human thymus is modulated by INS VNTR alleles at the IDDM2 locus. Nat Genet 1997: 15: 289-292.
116. Pugliese A, Zeller M, Fernandez A Jr et al. The insulin gene is transcribed in the human thymus and transcription levels correlated with allelic variation at the INS VNTR-IDDM2 susceptibility locus for type 1 diabetes. Nat Genet 1997: 15: 293-297.
117. Vafiadis P, Ounissi-Benkalha H, Palumbo M et al. Class III alleles of the variable number of tandem repeat insulin polymorphism associated with silencing of thymic insulin predispose to type 1 diabetes. J Clin Endocrinol Metab 2001: 86: 3705-3710.
118. Vyse TJ, Todd JA. Genetic analysis of autoimmune disease. Cell 1996: 85: 311-318.
119. Wicker LS, Todd JA, Peterson LB. Genetic control of autoimmune diabetes in the NOD mouse. Annu Rev Immunol 1995: 13: 179-200.
120. Cardon LR, Abecasis GR. Using haplotype blocks to map human complex trait loci. Trends Genet 2003: 19: 135-140.
121. Daly MJ, Rioux JD, Schaffner SF, Hudson TJ, Lander ES. High-resolution haplotype structure in the human genome. Nat Genet 2001: 29: 229-232.
122. Gabriel SB, Schaffner SF, Nguyen H et al. The structure of haplotype blocks in the human genome. Science 2002: 296: 2225-2229.
123. Johnson GC, Esposito L, Barratt BJ et al. Haplotype tagging for the identification of common disease genes. Nat Genet 2001: 29: 233-237.
124. Allcock RJ, Atrazhev AM, Beck S et al. The MHC haplotype project: a resource for HLA-linked association studies. Tissue Antigens 2002: 59: 520-521.
125. Bennett ST, Wilson AJ, Esposito L et al. Insulin VNTR allele-specific effect in type 1 diabetes depends on identity of untransmitted paternal allele. The IMDIAB Group Nat Genet 1997: 17: 350-352.
126. Polychronakos C, Giannoukakis N, Deal CL. Imprinting of IGF2, insulin-dependent diabetes, immune function, and apoptosis: a hypothesis. Dev Genet 1995: 17: 253-262.
127. Yamagata K, Furuta H, Oda N et al. Mutations in the hepatocyte nuclear factor-4alpha gene in maturity-onset diabetes of the young (MODY1). Nature 1996: 384: 458-460.
128. Vionnet N, Stoffel M, Takeda J et al. Nonsense mutation in the glucokinase gene causes early-onset non- insulin-dependent diabetes mellitus. Nature 1992: 356: 721-722.
129. Yamagata K, Oda N, Kaisaki PJ et al. Mutations in the hepatocyte nuclear factor-1alpha gene in maturity-onset diabetes of the young (MODY3). Nature 1996: 384: 455-458.
130. Stoffers DA, Ferrer J, Clarke WL, Habener JF. Early-onset type-II diabetes mellitus (MODY4) linked to IPF1. Nat Genet 1997: 17: 138-139.
131. Horikawa Y, Iwasaki N, Hara M et al. Mutation in hepatocyte nuclear factor-1 beta gene (TCF2) associated with MODY. Nat Genet 1997: 17: 384-385.
132. Malecki MT, Jhala US, Antonellis A et al. Mutations in NEUROD1 are associated with the development of type 2 diabetes mellitus. Nat Genet 1999: 23: 323-328.
133. Nagamine K, Peterson P, Scott HS et al. Positional cloning of the APECED gene. Nat Genet 1997: 17: 393-398.
134. The Finnish-German APECED Consortium. An autoimmune disease, APECED, caused by mutations in a novel gene featuring two PHD-type zinc-finger domains. Autoimmune Polyendocrinopathy-Candidiasis-Ectodermal Dystrophy. Nat Genet 1997: 17: 399-403.
135. Inoue H, Tanizawa Y, Wasson J et al. A gene encoding a transmembrane protein is mutated in patients with diabetes mellitus and optic atrophy (Wolfram syndrome) Nat Genet 1998: 20: 143-148.
136. Feder JN, Gnirke A, Thomas W et al. A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis. Nat Genet 1996: 13: 399-408.
137. Yoshida K, Furihata K, Takeda S et al. A mutation in the ceruloplasmin gene is associated with systemic hemosiderosis in humans. Nat Genet 1995: 9: 267-272.
138. Campuzano V, Montermini L, Molto MD et al. Friedreich's ataxia: autosomal recessive disease caused by an intronic GAA triplet repeat expansion. Science 1996: 271: 1423-1427.
139. Agarwal AK, Arioglu E, De Almeida S et al. AGPAT2 is mutated in congenital generalized lipodystrophy linked to chromosome 9q34. Nat Genet 2002: 31: 21-23.
140. Magre J, Delepine M, Khallouf E et al. Identification of the gene altered in Berardinelli-Seip congenital lipodystrophy on chromosome 11q13. Nat Genet 2001: 28: 365-370.
141. Cao H, Hegele RA. Nuclear lamin A/C R482Q mutation in canadian kindreds with Dunnigan- type familial partial lipodystrophy. Hum Mol Genet 2000: 9: 109-112.
142. Shackleton S, Lloyd DJ, Jackson SN et al. LMNA, encoding lamin A/C, is mutated in partial lipodystrophy. Nat Genet 2000: 24: 153-156.
143. Robbins DC, Blix PM, Rubenstein AH et al. A human proinsulin variant at arginine 65. Nature 1981: 291: 679-681.
144. Haneda M, Chan SJ, Kwok SC, Rubenstein AH, Steiner DF. Studies on mutant human insulin genes: identification and sequence analysis of a gene encoding [SerB24]insulin. Proc Natl Acad Sci USA 1983: 80: 6366-6370.
145. Moller DE, Flier JS. Detection of an alteration in the insulin-receptor gene in a patient with insulin resistance, acanthosis nigricans, and the polycystic ovary syndrome (type A insulin resistance). N Engl J Med 1988: 319: 1526-1529.
146. Yoshimasa Y, Seino S, Whittaker J et al. Insulin-resistant diabetes due to a point mutation that prevents insulin proreceptor processing. Science 1988: 240: 784-787.
147. Kadowaki T, Bevins CL, Cama A et al. Two mutant alleles of the insulin receptor gene in a patient with extreme insulin resistance. Science 1988: 240: 787-790.
148. Jackson RS, Creemers JW, Ohagi S et al. Obesity and impaired prohormone processing associated with mutations in the human prohormone convertase 1 gene. Nat Genet 1997: 16: 303-306.
149. Bennett CL, Christie J, Ramsdell F et al. The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3. Nat Genet 2001: 27: 20-21.
150. Wildin RS, Ramsdell F, Peake J et al. X-linked neonatal diabetes mellitus, enteropathy and endocrinopathy syndrome is the human equivalent of mouse scurfy. Nat Genet 2001: 27: 18-20.
151. Delepine M, Nicolino M, Barrett T, Golamaully M, Lathrop GM, Julier C. EIF2AK3, encoding translation initiation factor 2-alpha kinase 3, is mutated in patients with Wolcott-Rallison syndrome. Nat Genet 2000: 25: 406-409.
152. Merriman T, Twells R, Merriman M et al. Evidence by allelic association-dependent methods for a type 1 diabetes polygene (IDDM6) on chromosome 18q21. Hum Mol Genet 1997: 6: 1003-1010.
153. Morahan G, Huang D, Ymer SI et al. Linkage disequilibrium of a type 1 diabetes susceptibility locus with a regulatory IL12B allele. Nat Genet 2001: 27: 218-221.
154. Kristiansen OP, Nolsoe RL, Holst H et al. The intercellular adhesion molecule-1 K469E polymorphism in type 1 diabetes. Immunogenetics 2000: 52: 107-111.
155. Awata T, Matsumoto C et al. Association of polymorphism in the interferon gamma gene with IDDM. Diabetologia 1994: 37: 1159-1162.
156. Veijola R, Knip M, Puukka R et al. The immunoglobulin heavy-chain variable region in insulin-dependent diabetes mellitus: affected-sib-pair analysis and association studies. Am J Hum Genet 1996: 59: 462-470.
157. Bergholdt R, Karlsen AE, Johannesen J et al. Characterization of polymorphisms of an interleukin 1 receptor type 1 gene (IL1RI) promotor region (P2) and their relation to insulin-dependent diabetes mellitus (IDDM). The Danish Study Group Diabetes in Childhood. Cytokine 1995: 7: 727-733.
158. Jahromi MM, Millward BA, Demaine AG. A polymorphism in the promoter region of the gene for interleukin-6 is associated with susceptibility to type 1 diabetes mellitus. J Interferon Cytokine Res 2000: 20: 885-888.
159. Iwata I, Nagafuchi S, Nakashima H et al. Association of polymorphism in the NeuroD/BETA2 gene with type 1 diabetes in the Japanese. Diabetes 1999: 48: 416-419.
160. Kretowski A, Kinalska I. L-selectin gene T668C mutation in type 1 diabetes patients and their first degree relatives. Immunol. Lett 2000: 74: 225-228.
161. McDermott MF, Ramachandran A, Ogunkolade BW et al. Allelic variation in the vitamin D receptor influences susceptibility to IDDM in Indian Asians. Diabetologia 1997: 40: 971-975.
162. Chang TJ, Lei HH, Yeh JI et al. Vitamin D receptor gene polymorphisms influence susceptibility to type 1 diabetes mellitus in the Taiwanese population. Clin Endocrinol (Oxf) 2000: 52: 575-580.
163. Awata T, Inoue K, Kurihara S et al. Missense variations of the gene responsible for Wolfram syndrome (WFS1/wolframin) in Japanese: possible contribution of the Arg456His mutation to type 1 diabetes as a nonautoimmune genetic basis. Biochem Biophys Res Commun 2000: 268: 612-616.